<DOC>
	<DOCNO>NCT01715779</DOCNO>
	<brief_summary>The objective observational study characterize long-term ( 5 year post event ) clinical outcome patient experience thromboembolic event ( TEE ) participation GSK ENABLE clinical trial . Patients eligible study patient experience TEE participation ENABLE trial . Each include patient follow period 5 year date first TEE . Demographic clinical characteristic collect index date ( time TEE ) every sixth month follow-up period , information collect outcomes interest : mortality , new TEE , hepatic decompensation , evaluation liver transplant result evaluation , liver transplantation . All information collect medical record review .</brief_summary>
	<brief_title>Follow-up Study Patients Who Experienced Thromboembolic Events ENABLE Studies</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>Patients portal vein thrombosis ( PVT ) Patients deep vein thrombosis ( DVT ) Patients pulmonary embolism ( PE ) Patients myocardial infarction ( MI ) Patients unstable angina Patients transient ischemic attack ( TIA ) Patients ischemic stroke Patients TEE include embolism , thrombosis , phlebitis , thrombophlebitis location There exclusion criterion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>ENABLE</keyword>
	<keyword>observational</keyword>
	<keyword>mortality</keyword>
	<keyword>Thromboembolic Events</keyword>
	<keyword>Hepatic decompensation</keyword>
	<keyword>Long-Term follow-up</keyword>
	<keyword>TEE</keyword>
</DOC>